Prime, M. E., S. M. Courtney, F. A. Brookfield, R. W. Marston, V. Walker, J. Warne, A. E. Boyd, N. A. Kairies, W. von der Saal, A. Limberg, G. Georges, R. A. Engh, B. Goller, P. Rueger and M. Rueth: Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase. In: Journal of Medicinal Chemistry 54, 1, 312-319 (2011).
Bonn, S., S. Herrero, C. B. Breitenlechner, A. Erlbruch, W. Lehmann, R. A. Engh, M. Gassel and D. Bossemeyer: Structural analysis of protein kinase A mutants with Rho-kinase inhibitor specificity. In: Journal of Biological Chemistry 281, 34, 24818-24830 (2006).
Breitenlechner, C. B., N. A. Kairies, K. Honold, S. Scheiblich, H. Koll, E. Greiter, S. Koch, W. Schafer, R. Huber and R. A. Engh: Crystal structures of active Src kinase domain complexes. In: Journal of Molecular Biology 353, 2, 222-231 (2005).
Wisniewska, M., B. Bossenmaier, G. Georges, F. Hesse, M. Dangl, K. P. Kunkele, I. Ioannidis, R. Huber and R. A. Engh: The 1.1 angstrom resolution crystal structure of the p130cas SH3 domain and ramifications for ligand selectivity. In: Journal of Molecular Biology 347, 5, 1005-1014 (2005).
Breitenlechner, C. B., W. G. Friebe, E. Brunet, W. Guido, M. Graul, U. Thomas, K. P. Kunkele, W. Schafer, M. Gassel, D. Bosseineyer, R. Huber, R. A. Engh and B. Masjost: Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase a and mutants. In: Journal of Medicinal Chemistry 48, 1, 163-170 (2005).
Siwanowicz, I., G. M. Popowicz, M. Wisniewska, R. Huber, K. P. Kuenkele, K. Lang, R. A. Engh and T. A. Holak: Structural basis for the regulation of insulin-like growth factors by IGF binding proteins. In: Structure 13, 1, 155-167 (2005).
Breitenlechner, C., R. A. Engh, R. Huber, V. Kinzel, D. Bossemeyer and M. Gassel: The typically disordered n-terminus of PKA can fold as a helix and project the myristoylation site into solution. In: Biochemistry 43, 24, 7743-7749 (2004).
Gassel, M., C. B. Breitenlechner, N. Konig, R. Huber, R. A. Engh and D. Bossemeyer: The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase A. In: Journal of Biological Chemistry 279, 22, 23679-23690 (2004).
Breitenlechner, C. B., T. Wegge, L. Berillon, K. Graul, M. Marzenell, W. G. Friebe, U. Thomas, R. Schumacher, R. Huber, R. A. Engh and B. Masjost: Structure-based optimization of novel azepane derivatives as PKB inhibitors. In: Journal of Medicinal Chemistry 47, 6, 1375-1390 (2004).
Klein, C., F. Hesse, A. Dehner, R. A. Engh, M. Schwaiger and S. Hansen: In vitro folding and characterization of the p53 DNA binding domain. In: Biological Chemistry 385, 1, 95-102 (2004).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.